Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus

RNA

Volumn 10, Issue 8, 2004, Pages 1277-1290

  Hwang, Byounghoon ^a   Cho, Jung Sun ^a   Yeo, Hyeon Ju ^a   Kim, Jung Hye ^a   Chung, Kyung Min ^b   Han, Kyungsook ^c   Jang, Sung Key ^b   Lee, Seong Wook ^a  

^a Dankook University   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c Inha University   (South Korea)

Author keywords

HCV; HCV replicon; Intracellular protein detection; NS3 helicase; RNA aptamer; SELEX

Indexed keywords

APTAMER; HELICASE; STRUCTURAL PROTEIN;

ARTICLE; CELL PROLIFERATION; COMPETITIVE INHIBITION; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HEPATITIS C VIRUS; HEPATOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MOTIF; PROTEIN SECONDARY STRUCTURE; RECEPTOR AFFINITY; REPLICON; RNA METABOLISM; VIRUS GENOME; VIRUS ISOLATION; VIRUS REPLICATION;

ADENOSINE TRIPHOSPHATASES; BINDING SITES; HEPACIVIRUS; HEPATITIS C; HUMANS; PROTEIN BINDING; RNA; RNA HELICASES;

HEPATITIS C VIRUS;

EID: 3342877385     PISSN: 13558382     EISSN: None     Source Type: Journal    
DOI: 10.1261/rna.7100904     Document Type: Article

References (56)

1. Artsaenko, O., Tessmann, K., Sack, M., Haussinger, D., and Heintges, T. 2003. Abrogation of hepatitis C virus NS3 helicase enzymatic activity by recombinant human antibodies. J. Gen. Virol. 84: 2323-2332.
2. Bae, S.-J., Oum, J.-H., Sharma, S., Park, J., and Lee, S.-W. 2002. In vitro selection of specific RNA inhibitors of NFATc. Biochem. Biophys. Res. Comm. 298: 486-492.
3. Banerjee, R. and Dasgupta, A. 2001. Specific interaction of hepatitis C virus protease/helicase NS3 with the 3′-terminal sequences of viral positive- and negative-strand RNA. J. Virol. 75: 1708-1721.
4. Bartenschlager, R., Ahlborn-Laake, L., Mous, J., and Jacobsen, H. 1993. Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J. Virol. 67: 3835-3844.
5. Biroccio, A., Hamm, J., Incitti, I., De Francesco, R., and Tomei, L. 2002. Selection of RNA aptamers that are specific and high-affinity ligands of the hepatitis C virus RNA-dependent RNA polymerase. J. Virol. 76: 3688-3696.
6. Borowski, P., Deinert, J., Schalinski, S., Bretner, M., Ginalski, K., Kulikowski, T., and Shugar, D. 2003. Halogenated benzimidazoles and benzotriazoles as inhibitors of the NTPase/helicase activities of hepatitis C and related viruses. Eur. J. Biochem. 270: 1645-1653.
7. Burgstaller, P., Girod, A., and Blind, M. 2002. Aptamers as tools for target prioritization and lead identification. Drug Discov. Today 7: 1221-1228.
8. Cho, H.-S., Ha, N-C., Kang, L.-W., Chung, K.M., Back, S.H., Jang, S.K., and Oh, B.-H. 1998. Crystal structure of RNA helicase from genotype 1b hepatitis C virus. J. Biol. Chem. 273: 15045-15052.
9. Choo, Q.L., Richman, K.H., Han, J.H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D., Medina-Selby, R., Barr, P.J., et al. 1991. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. 88: 2451-2455.
10. De Francesco, R. and Steinkühler, C. 2000. Structure and function of the hepatitis C virus NS3-NS4A serine protease. Curr. Top. Microbiol. Immunol. 242: 149-169.
11. Ellington, A.D. and Szostak, J.W. 1990. In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822.
12. Feramisco, J.R., Smart, J.E., Burridge, K., Helfman, D.M., and Thomas, G.P. 1982. Co-existence of vinculin and a vinculin-like protein of higher molecular weight in smooth muscle. J. Biol. Chem. 257: 11024-11031.
13. Fukuda, K., Vishnuvardhan, D., Sekiya, S., Hwang, J., Kakiuchi, N., Taira, K., Shimotohno, K., Kumar, P.K., and Nishikawa, S. 2000. Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease. Eur. J. Biochem. 267: 3685-3694.
14. Gold, L., Allen, P., Binkley, J., Brown, D., Schneider, D., Eddy, S.R., Tuerk, C., Green, L., Macdougal, S., and Tasset, D. 1993. RNA: the shape of things to come. In The RNA World (eds. R.F. Gestelend and J.F. Atkins), pp. 497-510, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
15. Grakoui, A., McCourt, D.W., Wychowski, C., Feinstone, S.M., and Rice, C.M. 1993. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J. Virol. 67: 2832-2843.
16. Gwack, Y., Kim, D.W., Han, J.H., and Choe, J. 1996. Characterization of RNA binding activity and RNA helicase activity of the hepatitis C virus NS3 protein. Biochem. Biophys. Res. Comm. 225: 654-659.
17. Hijikata, M., Mizushima, H., Akagi, T., Mori, S., Kakiuchi, N., Kato, N., Tanaka, T., Kimura, K., and Shimotohno, K. 1993. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J. Virol. 67: 4665-4675.
18. Hwang, B., Han, K., and Lee, S.-W. 2003. Prevention of passively transferred experimental autoimmune myasthenia gravis by an in vitro selected RNA aptamer. FEBS Lett. 548: 85-89.
19. Jaeger, J., Turner, D., and Zuker, M. 1989. Improved predictions of secondary structures for RNA. Proc. Natl. Acad. Sci. 86: 7706-7710.
20. Kanai, A., Tanabe, K., and Kohara, M. 1995. Poly(U) binding activity of hepatitis C virus NS3 protein, a putative RNA helicase. FEBS Lett. 376: 221-224.
21. Khu, Y.-L., Koh, E., Lim, S.P., Tan, Y.H., Brenner, S., Lim, S.G., Hong, W.J., and Goh, P.-Y. 2001. Mutations that affect dimer formation and helicase activity of the hepatitis C virus helicase. J. Virol. 75: 205-214.
22. Kim, D.W., Gwak, Y., Han, J.H., and Choe, J. 1995. C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity. Biochem. Biophys. Res. Comm. 215: 160-166.
23. Kim, D.W., Kim, J., Gwack, Y., Han, J.H., and Choe, J. 1997. Mutational analysis of the hepatitis C virus RNA helicase. J. Virol. 71: 9400-9409.
24. Kim, J.L., Morgenstern, K.A., Griffith, J.P., Dwyer, M.D., Thomson, J.A., Murcko, M.A., Lin, C., and Caron, P.R. 1998. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure 6: 89-100.
25. Kim, J.W., Seo, M.Y., Shelat, A., Kim, C.S., Kwon, T.W., Lu, H.-h., Moustakas, D.T., Sun, J., and Han, J.H. 2003. Structurally conserved amino acid W5011 is required for RNA helicase activity but is not essential for DNA helicase activity of hepatitis C virus NS3 protein. J. Virol. 77: 571-582.
26. Krieger, N., Lohmann, V., and Bartenschlager, R. 2001. Enhancement of hepatitis C virus RNA replication by cell culture-adative mutations. J. Virol. 75: 4614-4624.
27. Kumar, P.K., Machida, K., Urvil, P.T., Kakiuchi, N., Vishnuvardhan, D., Shimotohno, K., Taira, K., and Nishikawa, S. 1997. Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA. Virology 237: 270-282.
28. Kwong, A.D., Kim, J.L., and Lin, C. 2000. Structure and function of hepatitis C virus NS3 helicase. Curr. Top. Microbiol. Immunol. 242: 171-196.
29. Lauer, G.M. and Walker, B.D. 2001. Hepatitis C virus infection. New Engl. J. Med. 345: 41-52.
30. Lee, S.-W. and Sullenger, B. 1996. Isolation of a nuclease resistant decoy RNA that selectively blocks autoantibody binding to insulin receptors on human lymphocytes. J. Exp. Med. 194: 315-324.
31. -. 1997. Isolation of a nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies. Nature Biotechnol. 15: 41-45.
32. Lin, C., Lindenbach, B.D., Pragai, B.M., McCourt, D.W., and Rice, C.M. 1994. Processing in the hepatitis C virus E2-NS2 region: Identification of p7 and two distinct E2-specific products with different C termini. J. Virol. 68: 5063-5073.
33. Liu, D., Wang, Y.S., Gesell, J.J., and Wyss, D.F. 2001. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase. J. Mol. Biol. 314: 543-561.
34. Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L., and Bartenschlager, R. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285: 110-113.
35. Manabe, S., Fuke, I., Tanishita, O., Kaji, C., Gomi, Y., Yoshida, S., Mori, C., Takamizawa, A., Yashida, I., and Okayama, H. 1994. Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. Virology 198: 636-644.
36. Mizushima, H., Hijikata, M., Tanji, Y., Kimura, K., and Shimotohno, K. 1994. Analysis of N-terminal processing of hepatitis C virus nonstructural protein 2. J. Virol. 68: 2731-2734.
37. Moradpour, D., Brass, V., Gosert, R., Wolk, B., and Blum, H. 2002. Hepatitis C: molecular virology and antiviral targets. Trends Mol. Med. 8: 476-482.
38. Nishikawa, F., Kakiuchi, N., Funaji, K., Fukuda, K., Sekiya, S., and Nishikawa, S. 2003. Inhibition of HCV NS3 protease by RNA aptamers in cells. Nucleic Acids Res. 31: 1935-1943.
39. Paul, C.P., Good, P.D., Li, S.X., Kleihauer, A., Rossi, J.J., and Engelke, D.R. 2003. Localized expression of small RNA inhibitors in human cells. Mol. Ther. 7: 237-247.
40. Penin, F., Dubuisson, J., Rey, F., Moradpour, D., and Pawlotsky, J.-M. 2004. Structural biology of hepatitis C virus. Hepatology 39: 5-19.
41. Preugschat, F., Averett, D.R., Clark, B.E., and Porter, D.J.T. 1996. A steady-state and pre-steady-state kinetic analysis of the NTPase activity associated with the hepatitis C virus NS3 helicase domain. J. Biol. Chem. 271: 24449-24457.
42. Rosemeyer, V., Laubrock, A., and Seibl, R. 1995. Nonradioactive 3′-end-labeling of RNA molecules of different lengths by terminal deoxynucleotidyltransferase. Anal. Biochem. 224: 446-449.
43. Rusconi, C.P., Scardino, E., Layzer, J., Pitoc, G.A., Ortel, T.L., Monroe, D., and Sullenger, B.A. 2002. RNA aptamers as reversible antagonists of coagulation factor IXa. Nature 419: 90-94.
44. Satoh, S., Tanji, Y., Hijikata, M., Kimura, K., and Shimotohno, K. 1995. The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A. J. Virol. 69: 4255-4260.
45. Shoji, I., Suzuki, T., Sato, M., Aizaki, H., Chiba, T., Matsuura, Y., and Miyamura, T. 1999. Internal processing of hepatitis C virus NS3 protein. Virology 254: 315-323.
46. Sullenger, B.A. and Gilboa, E. 2002. Emerging clinical applications of RNA. Nature 418: 252-258.
47. Suzich, J.A., Tamura, J.K., Palmer-Hill, F., Warrener, P., Grakoui, A., Rice, C.M., Feinstone, S.M., and Collett, M.S. 1993. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J. Virol. 67: 6152-6158.
48. Tai, C.-L., Chi, W.-K., Chen, D.-S., and Hwang, L.-H. 1996. The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). J. Virol. 70: 8477-8484.
49. Takamizawa, A., Mori, C., Fuke, I., Manabe, S., Murakami, S., Fujita, J., Onishi, E., Andoh, T., Yoshida, I., and Okayama, H. 1991. Structure and organization of the hepatitis C virus genome isolated from human carriers. J. Virol. 65: 1105-1113.
50. Tomei, L., Failla, C., Santolini, E., DeFrancesco, R., and LaMonica, N. 1993. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J. Virol. 67: 4017-4026.
51. Tuerk, C. and Gold, L. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505-510.
52. Urvil, P.T., Kakiuchi, N., Zhou, D.-M., Shimotohno, K., Kumar, P.K.R., and Nishikawa, S. 1997. Selection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus. Eur. J. Biochem. 248: 130-138.
53. Vo, N.V., Oh, J.W., and Lai, M.M. 2003. Identification of RNA ligands that bind hepatitis C virus polymerase selectively and inhibit its RNA synthesis from the natural viral RNA templates. Virology 307: 301-316.
54. Wardell, A.D., Errington, W., Ciaramella, G., Merson, J., and McGarvey, M.J. 1999. Characterization and mutational analysis of the helicase and NTPase activities of hepatitis C virus full-length NS3 protein. J. Gen. Virol. 80: 701-709.
55. Yang, S.H., Lee, C.G., Song, M.K., and Sung, Y.C. 2000. Internal cleavage of hepatitis C virus NS3 protein is dependent on the activity of NS34A protease. Virology 268: 132-140.
56. Yao, N., Hesson, T., Cable, M., Hong, Z., Kwong, A.D., Le, H.V., and Weber, P.C. 1997. Structure of the hepatitis C virus RNA helicase domain. Nat. Struct. Biol. 4: 463-467.